Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.

Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.

Item
http://www.wikidata.org/entity/Q44358596
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma.Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease: An 8-Year Nationwide Cohort Study in Taiwan.Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection.Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.Optimal management of patients with chronic hepatitis C and comorbidities.Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection.Cost utility of telaprevir-PR (peginterferon-ribavirin) versus boceprevir-PR and versus PR alone in chronic hepatitis C in The Netherlands.β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer developmentThe spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management.Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues.Screening therapeutic targets of ribavirin in hepatocellular carcinoma.HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation
P2860

Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.

Item
http://www.wikidata.org/entity/Q44358596
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Treatment of patients with dua ...... lular carcinoma and mortality.
@en
Treatment of patients with dua ...... lular carcinoma and mortality.
@nl
type
label
Treatment of patients with dua ...... lular carcinoma and mortality.
@en
Treatment of patients with dua ...... lular carcinoma and mortality.
@nl
prefLabel
Treatment of patients with dua ...... lular carcinoma and mortality.
@en
Treatment of patients with dua ...... lular carcinoma and mortality.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Treatment of patients with dua ...... llular carcinoma and mortality
@en
P2093
P2860
P304
P31
P356
10.1136/GUTJNL-2012-304370
P407
P433
P478
P50
P577
P698